- Treatment of hepatitis C virus (HCV) infection
SOVIHEP 400
| MRP | : |
|
| Price | : | ₹3,500.00 |
| You Save | : | ₹11,937.34 (77.33%) |
28 tablet(s) in a bottle
Sovihep 400mg Tablet contains Sofosbuvir as its active ingredient. It is a direct-acting antiviral (DAA) agent used in the treatment of chronic hepatitis C virus (HCV) infection. Sovihep 400mg is typically used in combination with other antiviral medications to create a comprehensive treatment regimen aimed at eliminating the HCV virus from the body.
This medicine has notably reduced the treatment duration compared to older therapies and is considered effective across multiple HCV genotypes, offering broad-spectrum antiviral coverage. As a result, it is a flexible and widely applicable treatment option for various HCV-infected patient populations.
Sovihep 400mg is generally well-tolerated, with minimal serious side effects reported. However, it should not be used in individuals who are allergic or hypersensitive to Sofosbuvir or any of its components. Since this drug is primarily excreted through the kidneys, patients with severe renal impairment may require careful monitoring and possible dosage adjustments. Additionally, its safety and efficacy in children under 18 years of age have not been established, and thus, its use in the pediatric population is not currently recommended

